HR 4144
116th Congress
House
Health
Adoption and foster care
Cell biology and embryology
Child health
Emergency medical services and trauma care
Genetics
Health care costs and insurance
Health care coverage and access
Health care quality
Health programs administration and funding
Health technology, devices, supplies
Hospital care
Medicaid
Medical tests and diagnostic methods
State and local government operations
Ending the Diagnostic Odyssey Act of 2019
Introduced: August 2, 2019
Introduced by:
Peters, Scott H.
Democratic
· California
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2019
Referred to the Subcommittee on Health.
Aug 2, 2019
Referred to the House Committee on Energy and Commerce.
Aug 2, 2019
Introduced in House
Plain-English summary
Ending the Diagnostic Odyssey Act of 2019
This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.
Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.
The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2